HemaSphere
(Jun 2022)
P691: MODELLING OF IMMUNE RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS SUGGESTS POTENTIAL FOR TREATMENT REDUCTION PRIOR TO CESSATION
- E. Karg,
- C. Baldow,
- T. Zerjatke,
- R. E. Clark,
- I. Roeder,
- A. C. Fassoni,
- I. Glauche
Affiliations
- E. Karg
- 1 Institute for Medical Informatics and Biometry (IMB), TU Dresden, Dresden, Germany
- C. Baldow
- 1 Institute for Medical Informatics and Biometry (IMB), TU Dresden, Dresden, Germany
- T. Zerjatke
- 1 Institute for Medical Informatics and Biometry (IMB), TU Dresden, Dresden, Germany
- R. E. Clark
- 2 Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom
- I. Roeder
- 1 Institute for Medical Informatics and Biometry (IMB), TU Dresden, Dresden, Germany
- A. C. Fassoni
- 4 Instituto de Matemática e Computação, Universidade Federal de Itajubá, Itajubá, Brazil
- I. Glauche
- 1 Institute for Medical Informatics and Biometry (IMB), TU Dresden, Dresden, Germany
- DOI
-
https://doi.org/10.1097/01.HS9.0000845648.71966.87
- Journal volume & issue
-
Vol. 6
pp.
586
– 587
WeChat QR code